TELA
Tela Bio Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 80.3M | 69.3M | 58.5M | 41.4M | 29.5M | 18.2M | 15.4M | 8.3M | 4.2M |
| Cost of Revenue | — | — | — | — | — | — | — | — | — |
| Gross Profit | 54.3M | 46.5M | 40.1M | 27.0M | 18.8M | 11.2M | 9.3M | 2.9M | 2.5M |
| Operating Expenses | |||||||||
| R&D Expenses | — | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — | — |
| Total Op. Expenses | — | — | — | — | — | — | — | — | — |
| Operating Income | -33.8M | -34.1M | -44.1M | -39.0M | -29.5M | -25.3M | -19.2M | -17.8M | -16.9M |
| EBITDA | — | — | — | — | — | — | — | — | — |
| Below the Line | |||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — |
| Pre-Tax Income | — | — | — | — | — | — | — | — | — |
| Income Tax | — | — | — | — | — | — | — | — | — |
| Net Income | -38.8M | -37.8M | -46.7M | -44.3M | -33.3M | -28.8M | -22.4M | -21.1M | -21.3M |
| Per Share | |||||||||
| EPS (basic) | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | — | — | — | — | — | — | — | — |
| Shares | |||||||||
| Basic Shares | — | — | — | — | — | — | — | — | — |
| Diluted Shares | 47M | 29M | 23M | 16M | 14M | 13M | 2M | 0M | — |